Uremia: Difference between revisions
No edit summary |
(added internal links) |
||
| Line 21: | Line 21: | ||
**Similar to uremic encephalopathy except progressive, no improvement w/ dialysis | **Similar to uremic encephalopathy except progressive, no improvement w/ dialysis | ||
**EEG findings can differentiate uremic encephalopathy from dialysis dementia | **EEG findings can differentiate uremic encephalopathy from dialysis dementia | ||
*CVA | *[[CVA]] | ||
**Cerebrovascular disease, trauma, bleeding dyscrasias, anticoagulant, HTN | **Cerebrovascular disease, trauma, bleeding dyscrasias, anticoagulant, HTN | ||
*Subdural hematoma | *[[Subdural hematoma]] | ||
**10x more likely than in general population | **10x more likely than in general population | ||
**Headache, focal neurologic deficits, seizure, coma | **Headache, focal neurologic deficits, seizure, coma | ||
| Line 39: | Line 39: | ||
**Circulating digitalis-like substances have been implicated | **Circulating digitalis-like substances have been implicated | ||
**Dialysis rarely improves LV function | **Dialysis rarely improves LV function | ||
*Pericarditis | *[[Pericarditis]] | ||
**Uremic pericarditis (75% of cases) | **Uremic pericarditis (75% of cases) | ||
***Most common when the other symptoms of uremia are most severe | ***Most common when the other symptoms of uremia are most severe | ||
| Line 51: | Line 51: | ||
**Treatment | **Treatment | ||
***Dialysis | ***Dialysis | ||
*Tamponade | *[[Tamponade]] | ||
**Presents w/ AMS, hypotension, dyspnea | **Presents w/ AMS, hypotension, dyspnea | ||
***Rarely present w/ classic signs of Beck's triad | ***Rarely present w/ classic signs of Beck's triad | ||
**Pericardiocentesis should only be attempted if hemodynamically unstable | **Pericardiocentesis should only be attempted if hemodynamically unstable | ||
*Pulmonary Edema | *[[Pulmonary Edema]] | ||
**Commonly ascribed to fluid overload; also consider MI | **Commonly ascribed to fluid overload; also consider MI | ||
***Treat similar to non-ESRD pt | ***Treat similar to non-ESRD pt | ||
| Line 62: | Line 62: | ||
****Induced diarrhea (sorbitol) | ****Induced diarrhea (sorbitol) | ||
****Phlebotomy - withdrawal of as little as 150 mL is safe and effective | ****Phlebotomy - withdrawal of as little as 150 mL is safe and effective | ||
*CHF | *[[CHF]] | ||
**May be preexisting | **May be preexisting | ||
**May be caused by uremic cardiomyopathy, fluid overload, AV-related high-output failure | **May be caused by uremic cardiomyopathy, fluid overload, AV-related high-output failure | ||
===Hematologic=== | ===Hematologic=== | ||
*Anemia | *[[Anemia]] | ||
**Without tx the hematocrit in ESRD pts should stabilize at 15-20% | **Without tx the hematocrit in ESRD pts should stabilize at 15-20% | ||
**Treatment = erythropoietin | **Treatment = erythropoietin | ||
| Line 76: | Line 76: | ||
===GI=== | ===GI=== | ||
*Anorexia, N/V | *Anorexia, [[N/V]] | ||
*Increased incidence of GI bleeding, diverticular disease, ascites | *Increased incidence of GI bleeding, diverticular disease, ascites | ||
Revision as of 17:29, 4 September 2015
Background
- Uremia = clinical syndrome a/w end-stage renal disease (contamination of blood w/ urine)
- Correlation exists between uremia symptoms and low GFR (15-20% of nl)
- BUN/Cr are inaccurate markers of clinical syndrome of uremia
- Contributing Factors:
- Excretory failure
- Leads to toxin accumulation
- Biosynthetic failure
- Loss of Vitamin D and erythropoietin
- Regulatory failure
- Uremic state produces excess free radicals -> atherosclerosis, amyloidosis
- Excretory failure
Clinical Features and Management
Neurologic
- Uremic encephalopathy
- Diagnosis of exclusion
- Cognitive defects, memory loss, decreased attentiveness, slurred speech
- Asterixis, seizure, coma
- Improves w/ dialysis
- Dialysis dementia
- Similar to uremic encephalopathy except progressive, no improvement w/ dialysis
- EEG findings can differentiate uremic encephalopathy from dialysis dementia
- CVA
- Cerebrovascular disease, trauma, bleeding dyscrasias, anticoagulant, HTN
- Subdural hematoma
- 10x more likely than in general population
- Headache, focal neurologic deficits, seizure, coma
- Peripheral neuropathy
- Occurs in 60-100% of dialysis pts
- Paresthesias, impaired proprioception, weakness
- Autonomic neuropathy (postural dizziness, gastroparesis, bowel dysfunction)
Cardiovascular
- CK-MB and troponin are specific markers of MI even in pts undergoing regular dialysis
- Mortality from CV disease is 10-30x higher in dialysis pts than general population
- HTN is common
- Uremic cardiomyopathy
- Diagnosis of exclusion
- Circulating digitalis-like substances have been implicated
- Dialysis rarely improves LV function
- Pericarditis
- Uremic pericarditis (75% of cases)
- Most common when the other symptoms of uremia are most severe
- BUN is nearly always >60
- Loud friction rub that is often palpable
- Typical pericarditis ECG changes are absent (inflammation does not involve myocardium)
- If ECG does have typical changes consider infection
- Dialysis-related (25% of cases)
- Most common during increased catabolism (trauma, sepsis) or missed dialysis sessions
- Constitutional symptoms, such as fever, are more common than in uremic pericarditis
- Treatment
- Dialysis
- Uremic pericarditis (75% of cases)
- Tamponade
- Presents w/ AMS, hypotension, dyspnea
- Rarely present w/ classic signs of Beck's triad
- Pericardiocentesis should only be attempted if hemodynamically unstable
- Presents w/ AMS, hypotension, dyspnea
- Pulmonary Edema
- Commonly ascribed to fluid overload; also consider MI
- Treat similar to non-ESRD pt
- Lasix 80mg IV may be effective even if minimal Urine output (pulmonary vasodilation)
- Preload reduction can be accomplished via:
- Induced diarrhea (sorbitol)
- Phlebotomy - withdrawal of as little as 150 mL is safe and effective
- Treat similar to non-ESRD pt
- Commonly ascribed to fluid overload; also consider MI
- CHF
- May be preexisting
- May be caused by uremic cardiomyopathy, fluid overload, AV-related high-output failure
Hematologic
- Anemia
- Without tx the hematocrit in ESRD pts should stabilize at 15-20%
- Treatment = erythropoietin
- Bleeding diathesis
- Increased risk for of bleeding (GI, ICH, liver hematoma) due to impaired plt function
- Treatment = desmopressin, cryoprecipitate, conjugated estrogen
- Immunodeficiency
GI
- Anorexia, N/V
- Increased incidence of GI bleeding, diverticular disease, ascites
Renal bone disease
- Metastatic calcification (calciphylaxis)
- When calcium-phosphate product (Ca x PO4) > 70-80, metastatic calcification can ensue
- Symptoms of pseudogout, skin/finger necrosis (small vessel involvement)
- Life-threatening calcifications can occur in the cardiac and pulmonary systems
- Tx = use of low-calcium dialysate and phosphate-binding gels
- Hyperparathyroidism (osteitis fibrosa cystica)
- Calciphylaxis + vitamin D3 deficiency results in depressed Ca, stimulation of PTH
- Leads to high bone turnover > weakened bones > increased fracture susceptibility
- Tx = phosphate binding gels, vitamin D3 replacement
- Vitamin D3 deficiency and aluminum intoxication (osteomalacia)
- Leads to osteomalacia (defect in bone calcification)
- Symptoms similar to hyperparathyroidism (muscle weakness, bone pain)
- Tx = desferrioxamine
- Amyloidosis
- Common in pts >50yr who have received dialysis for >10yr
- Complications: GI perforation, bone cysts w/ pathologic fx, arthropathies
